Tersera Therapeutics

QUZYTTIR

Manufacturer:

Tersera Therapeutics

Quzyttir HCPCS:

J1201

HCPCS Code Descriptor:

Injection, cetirizine hydrochloride, 0.5 mg

Category:

J Code

Quzyttir NDCs:

70720-0100-10, 70720-0100-25

Primary Type:

Antihistamine

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

70720-0100-25

About Quzyttir:

QUZYTTIR is an Antihistamine drug manufactured by Tersera Therapeutics and administered via the Intravenous route of administration. The J Code: J1201 is aligned to the drug QUZYTTIR.

ACCESS PRICING AND MORE BY REGISTERING

J1201 Added Date:

July 1, 2020

J1201 Effective Date:

July 1, 2020

J1201 Termination Date:

HCPCS Active

Quzyttir billing and coding information can be found through Tersera Therapeutics at the link below:
Quzyttir patient assistance information can be found through TerSera SupportSource at the URL: https://www.terserasupportsource.com/
QUZYTTIR prescribing information can be found at the link below:
Information regarding QUZYTTIR’s side effects can be found at MedlinePlus